Literature DB >> 8132782

Cellular distribution of insulin-degrading enzyme gene expression. Comparison with insulin and insulin-like growth factor receptors.

C A Bondy1, J Zhou, E Chin, R R Reinhardt, L Ding, R A Roth.   

Abstract

Insulin-degrading enzyme (IDE) hydrolyzes both insulin and IGFs and has been proposed to play a role in signal termination after binding of these peptides to their receptors. In situ hybridization was used to investigate the cellular distribution of IDE mRNA and to compare it with insulin receptor (IR) and IGF-I receptor (IGFR) gene expression in serial thin sections from a variety of tissues in embryonic and adult rats. IDE mRNA is highly abundant in kidney and liver, tissues known to play a role in insulin degradation. IDE and IR mRNAs are highly coexpressed in brown fat and liver. The highest level IDE gene expression, on a per cell basis, is found in germinal epithelium. IDE and IGFR mRNAs are colocalized in oocytes, while IDE is colocalized with the IGF-II receptor in spermatocytes, suggesting that IDE may be involved with degradation of IGF-II in the testis. In summary, IDE expression demonstrates significant anatomical correlation with insulin/IGF receptors. These data are compatible with a role for IDE in degrading insulin and IGFs after they bind to and are internalized with their respective receptors and may also suggest a novel role for IDE in germ cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132782      PMCID: PMC294007          DOI: 10.1172/JCI117103

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

Review 1.  Cellular proteolysis. An overview.

Authors:  A J Barrett
Journal:  Ann N Y Acad Sci       Date:  1992-12-31       Impact factor: 5.691

Review 2.  The new enzymology of precursor processing endoproteases.

Authors:  D F Steiner; S P Smeekens; S Ohagi; S J Chan
Journal:  J Biol Chem       Date:  1992-11-25       Impact factor: 5.157

3.  Insulin B chain-degrading neutral peptidase activity in the rat. Tissue distribution and the effects of starvation and streptozotocin-induced diabetes.

Authors:  B H Phelps; P T Varandani; L A Shroyer
Journal:  Arch Biochem Biophys       Date:  1979-06       Impact factor: 4.013

4.  Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.

Authors:  R A Roth; M L Mesirow; K Yokono; S Baba
Journal:  Endocr Res       Date:  1984       Impact factor: 1.720

5.  Insulin-like growth factor-II and its binding proteins in placental development.

Authors:  J Zhou; C Bondy
Journal:  Endocrinology       Date:  1992-09       Impact factor: 4.736

6.  Regulation of insulin degradation: expression of an evolutionarily conserved insulin-degrading enzyme increases degradation via an intracellular pathway.

Authors:  W L Kuo; B D Gehm; M R Rosner
Journal:  Mol Endocrinol       Date:  1991-10

7.  The rat insulin-degrading enzyme. Molecular cloning and characterization of tissue-specific transcripts.

Authors:  H Baumeister; D Müller; M Rehbein; D Richter
Journal:  FEBS Lett       Date:  1993-02-15       Impact factor: 4.124

8.  Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.

Authors:  W L Kuo; A G Montag; M R Rosner
Journal:  Endocrinology       Date:  1993-02       Impact factor: 4.736

9.  Inhibition of insulin degradation by insulin-like growth factors.

Authors:  R I Misbin; E C Almira; W C Duckworth; T D Mehl
Journal:  Endocrinology       Date:  1983-10       Impact factor: 4.736

10.  A high molecular weight metalloendoprotease from the cytosol of mammalian cells.

Authors:  R J Kirschner; A L Goldberg
Journal:  J Biol Chem       Date:  1983-01-25       Impact factor: 5.157

View more
  11 in total

1.  Toxoplasma gondii toxolysin 4 is an extensively processed putative metalloproteinase secreted from micronemes.

Authors:  Julie Laliberté; Vern B Carruthers
Journal:  Mol Biochem Parasitol       Date:  2011-01-26       Impact factor: 1.759

2.  Yeast Ste23p shares functional similarities with mammalian insulin-degrading enzymes.

Authors:  Benjamin J Alper; Jarrad W Rowse; Walter K Schmidt
Journal:  Yeast       Date:  2009-11       Impact factor: 3.239

Review 3.  Amylin-mediated control of glycemia, energy balance, and cognition.

Authors:  Elizabeth G Mietlicki-Baase
Journal:  Physiol Behav       Date:  2016-02-27

4.  Effect of dexamethasone and testosterone treatment on the regulation of insulin-degrading enzyme and cellular changes in ventral rat prostate after castration.

Authors:  Juliany S B César Vieira; Karina L A Saraiva; Maria C L Barbosa; Regina C C Porto; Juan C Cresto; Christina A Peixoto; Maria I Wanderley; Daniel P Udrisar
Journal:  Int J Exp Pathol       Date:  2011-04-21       Impact factor: 1.925

5.  A capillary electrophoresis method for evaluation of Abeta proteolysis in vitro.

Authors:  Benjamin J Alper; Walter K Schmidt
Journal:  J Neurosci Methods       Date:  2008-11-21       Impact factor: 2.390

6.  In vitro degradation of insulin-like peptide 3 by insulin-degrading enzyme.

Authors:  Wei-Jie Zhang; Xiao Luo; Zhan-Yun Guo
Journal:  Protein J       Date:  2010-02       Impact factor: 2.371

7.  Structure, function, and regulation of insulin-degrading enzyme.

Authors:  Raymond E Hulse; Luis A Ralat; Tang Wei-Jen
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

Review 8.  Targeting Insulin-Degrading Enzyme in Insulin Clearance.

Authors:  Malcolm A Leissring; Carlos M González-Casimiro; Beatriz Merino; Caitlin N Suire; Germán Perdomo
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

9.  Characterization of INS-15, A Metalloprotease Potentially Involved in the Invasion of Cryptosporidium parvum.

Authors:  Rui Xu; Yaqiong Guo; Na Li; Qiang Zhang; Haizhen Wu; Una Ryan; Yaoyu Feng; Lihua Xiao
Journal:  Microorganisms       Date:  2019-10-14

10.  Zinc Supplementation Improves Glucose Homeostasis in High Fat-Fed Mice by Enhancing Pancreatic β-Cell Function.

Authors:  Vinícius Cooper-Capetini; Diogo Antonio Alves de Vasconcelos; Amanda Roque Martins; Sandro Massao Hirabara; José Donato; Angelo Rafael Carpinelli; Fernando Abdulkader
Journal:  Nutrients       Date:  2017-10-20       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.